# CJC-1295 (no DAC)

Canonical source: https://retacompare.com/encyclopedia/cjc-1295

Stabilized GHRH analog without the drug affinity complex (DAC). Drives a clean GH pulse without the days-long elevation.

Reference facts

Also known asMod GRF 1-29, Modified GRFCategoryGrowth Hormone & GhrelinMechanism of actionStabilized GHRH analog without the drug affinity complex (DAC). Drives a clean GH pulse without the days-long elevation.TargetsGHRHRIndications under research or approvedOff-label research (adult GH support)Regulatory status (reference entry)Not FDA-approvedHalf-life~30 minutesSequenceYADAIFTNSYRKVLGQLSARKLLQDIMSRSequence notesTetrasubstituted Sermorelin: D-Ala²,Gln⁸,Ala¹⁵,Leu²⁷. The four substitutions resist DPP-4 cleavage and asparagine rearrangement.Molecular weight (Da)3367Originator / sponsorOriginally ConjuChem (research)First reported2005
    Primary References

Teichman et al., JCEM 2006 (CJC-1295 PK)


    Explore research articles about CJC-1295 (no DAC)


    This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.

## Sources

- Teichman et al., JCEM 2006 (CJC-1295 PK): https://pubmed.ncbi.nlm.nih.gov/16352683/